NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 13:30
NovaBridge Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0133 |
| September 30, 2025 | 0.0126 |
| June 30, 2025 | 0.0177 |
| March 31, 2025 | 0.0186 |
| December 31, 2020 | 0.0024 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0208 |
| December 31, 2019 | -1.591 |
| September 30, 2019 | 0.1018 |
| December 31, 2018 | -3.206 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Xencor, Inc. | 0.338 |
| Arrivent BioPharma, Inc. | 0.001 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 260.52M |
| Total Liabilities (Quarterly) | 29.58M |
| Shareholders Equity (Quarterly) | 230.94M |